Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedMelanoma and related topics: MedlinePlus Genetics were added as related topics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoChange DetectedIntroduced a new Locations section that lists Iowa, Minnesota, New Mexico, and Utah as study sites. Corresponding location entries for these states were removed from the previous content.SummaryDifference0.7%

- Check23 days agoChange DetectedMelanoma is added to the related topics section under MedlinePlus Genetics on the Study Details page.SummaryDifference0.2%

- Check37 days agoChange DetectedMelanoma and the related topic MedlinePlus Genetics were removed from the Related Topics/MeSH section. This change is a minor metadata adjustment that does not alter the study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page revision list now includes Revision: v3.3.2 added and Revision: v3.2.0 removed, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved a notice about a lapse in government funding and operating status. The page continues to display the study details, locations, and eligibility criteria.SummaryDifference0.4%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.